UPL 과거 순이익 실적
과거 기준 점검 4/6
UPL의 수입은 연평균 -30.1%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 6.1% 증가했습니다. 매출은 연평균 2.2%의 비율로 증가해 왔습니다. UPL의 자기자본이익률은 5.4%이고 순이익률은 3.7%입니다.
핵심 정보
-30.10%
순이익 성장률
-30.46%
주당순이익(EPS) 성장률
| Chemicals 산업 성장률 | 17.68% |
| 매출 성장률 | 2.25% |
| 자기자본이익률 | 5.38% |
| 순이익률 | 3.71% |
| 최근 순이익 업데이트 | 31 Mar 2026 |
최근 과거 실적 업데이트
Recent updates
내러티브 업데이트 • Jun 02
512070: Upcoming Governance Meetings Will Support Stronger Medium Term Re-Rating
Analysts have trimmed their fair value estimate for UPL slightly from ₹776.22 to ₹767.00, as modest adjustments to the discount rate and forward P/E assumptions offset essentially unchanged revenue growth and profit margin expectations. What's in the News Board meeting scheduled for May 11, 2026, at 11:15 IST to consider and approve audited consolidated and standalone financial results for the year ended March 31, 2026, and to consider recommending a dividend, if any (source: company board meeting notice).내러티브 업데이트 • May 18
512070: Upcoming Governance Meetings Will Support Stronger Medium Term Outlook
Analysts have trimmed their price target on UPL from ₹811.50 to ₹776.22, citing revised assumptions around profit margins, a higher future P/E multiple, and updated views on discount rates and revenue growth. What's in the News UPL has scheduled an Analyst/Investor Day, providing an opportunity to hear directly from management about the business and capital allocation plans.
내러티브 업데이트 • May 01
512070: Fair Pricing Will Depend On Execution Of Upcoming Restructuring And Treasury Plans
Analysts have trimmed their price target on UPL from ₹647.56 to ₹630.00, citing updated assumptions around revenue growth, profit margin, discount rate and future P/E that slightly adjust their valuation framework. What's in the News UPL has scheduled a Special or Extraordinary Shareholders Meeting on March 31, 2026, at 15:30 IST to consider and approve material related party transactions for sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).내러티브 업데이트 • Apr 17
512070: Composite Scheme And Governance Steps Will Support Stronger Medium Term Outlook
Analysts have trimmed their price target on UPL slightly from about ₹820.53 to ₹811.50, reflecting updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiple. What's in the News Board meeting on Feb 20, 2026 to consider a Composite Scheme of Arrangement among UPL Limited and multiple group entities under Sections 230 to 232 and 234 of the Companies Act, 2013, based on recommendations from the Audit Committee and the Committee of Independent Directors (company filing).
내러티브 업데이트 • Apr 03
512070: Upcoming Governance Decisions And Treasury Scheme Will Support A Stronger Outlook
Analysts have trimmed their price target on UPL from ₹975 to ₹947, citing updated assumptions on long term profit margins and P/E multiples, along with refreshed views on growth, discount rates and fair value. What's in the News UPL has called a Special or Extraordinary Shareholders Meeting for March 31, 2026, at 15:30 IST to seek approval for material related party transactions involving sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).내러티브 업데이트 • Mar 19
512070: Fair Pricing Will Rely On Execution Of Upcoming Restructuring Steps
Analysts have nudged their price target on UPL slightly higher to about ₹648 from roughly ₹641, citing updated assumptions around revenue growth, profit margins, a modestly lower discount rate, and a small adjustment to the expected future P/E multiple. What's in the News UPL has scheduled a board meeting on Feb 02, 2026 at 12:45 Indian Standard Time to consider and approve unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025, along with limited review reports from the statutory auditors (Key Developments).내러티브 업데이트 • Mar 05
512070: Composite Scheme Board Meeting Will Support Stronger Medium Term Outlook
Analysts have raised their price target on UPL by about ₹39 to ₹820, citing updated assumptions that reflect a slightly lower discount rate, a modest tweak to revenue growth and P/E expectations, and a higher projected profit margin. What's in the News Board meeting scheduled for Feb 20, 2026 at 14:30 IST to consider a Composite Scheme of Arrangement involving UPL and its subsidiaries UPL Sustainable Agri Solutions Limited, UPL Global Sustainable Agri Solutions Limited, and UPL Crop Protection Holdings Limited under Sections 230 to 232 and 234 of the Companies Act, 2013 (company filing).내러티브 업데이트 • Feb 18
512070: Revised Margins And Lower P/E Will Likely Struggle To Support Pricing
Analysts have raised their fair value estimate for UPL from ₹600.67 to ₹641.03, citing updated views on the discount rate, revenue growth, profit margins and future P/E assumptions. What's in the News Board meeting scheduled for Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).내러티브 업데이트 • Feb 04
512070: Higher Margin Assumptions And Upcoming Results Will Support A Stronger Fair Value Outlook
Analysts have raised their fair value estimate for UPL from ₹944 to ₹975, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News UPL has scheduled a board meeting on Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results.내러티브 업데이트 • Jan 21
512070: Higher Revenue And Margin Assumptions Will Support A Stronger Fair Value Outlook
Analysts have raised their fair value estimate for UPL from ₹911.93 to ₹944.00 after updating their assumptions for revenue growth, profit margins, discount rate and future P/E. What's in the News UPL has scheduled a Board Meeting on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Limited Review Reports from the statutory auditors (company filing).내러티브 업데이트 • Jan 07
512070: Small Assumption Tweaks Will Likely Fail To Prevent Margin Pressure
Analysts have slightly increased their fair value estimate for UPL from ₹596.98 to ₹600.67. This reflects small adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E multiples.내러티브 업데이트 • Dec 19
512070: Future Margins Will Likely Deteriorate Despite Higher Market Expectations
Analysts have raised their price target for UPL from approximately 526.51 to 596.98, citing slightly stronger expectations for revenue growth and future valuation multiples, partly offset by a more conservative view on profit margins and discount rates. What's in the News UPL Limited has scheduled a board meeting for November 06, 2025 to consider and approve unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the limited review reports from the statutory auditors (company filing).내러티브 업데이트 • Dec 05
512070: Board Meeting And Stable Assumptions Will Shape Medium Term Outlook
Analysts have modestly raised their price target for UPL to ₹781.39, reflecting slightly improved discount rate and future P E assumptions, while largely maintaining their views on growth and profitability. What's in the News A board meeting is scheduled on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Statutory Auditors' limited review reports (company filing).내러티브 업데이트 • Nov 21
512070: Board Meetings And Adjusted Forecasts Will Influence Medium-Term Outlook
Analysts have raised their price target for UPL from $756.34 to $781.39. This reflects optimism driven by slightly improved revenue growth expectations and adjustments to projected profit margins and valuation multiples.내러티브 업데이트 • Nov 07
512070: Upcoming Board Decisions And Steady Financials Will Shape Outlook
Analysts have raised their price target for UPL from $736.09 to $756.34. They cite modest improvements in profit margin and revenue growth forecasts as the reason for this adjustment.
새로운 내러티브 • Dec 10
Biosolutions Innovation And Improved Financial Stability Expected To Boost Earnings Growth
Strategic inventory management and sales mix enhancement are expected to boost margins and improve earnings.매출 및 비용 세부 내역
매출 및 비용 세부 내역
UPL가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 31 Mar 26 | 518,390 | 19,220 | 65,570 | 0 |
| 31 Dec 25 | 490,770 | 16,210 | 67,060 | 0 |
| 30 Sep 25 | 477,150 | 20,530 | 64,270 | 0 |
| 30 Jun 25 | 467,860 | 10,570 | 63,360 | 0 |
| 31 Mar 25 | 466,370 | 7,610 | 62,460 | 0 |
| 31 Dec 24 | 451,420 | -950 | 58,910 | 0 |
| 30 Sep 24 | 441,220 | -21,400 | 58,950 | 0 |
| 30 Jun 24 | 432,020 | -18,860 | 56,950 | 0 |
| 31 Mar 24 | 430,980 | -13,360 | 55,740 | 0 |
| 31 Dec 23 | 455,890 | -5,830 | 61,940 | 0 |
| 30 Sep 23 | 493,810 | 17,210 | 63,540 | 0 |
| 30 Jun 23 | 517,180 | 27,240 | 63,480 | 0 |
| 31 Mar 23 | 535,760 | 34,350 | 63,220 | 0 |
| 31 Dec 22 | 528,680 | 40,360 | 60,120 | 0 |
| 30 Sep 22 | 504,860 | 38,850 | 58,240 | 0 |
| 30 Jun 22 | 485,460 | 37,050 | 56,780 | 0 |
| 31 Mar 22 | 462,400 | 35,050 | 53,940 | 0 |
| 31 Dec 21 | 431,750 | 32,200 | 47,520 | 0 |
| 30 Sep 21 | 410,040 | 30,780 | 46,110 | 0 |
| 30 Jun 21 | 393,760 | 29,070 | 44,290 | 0 |
| 31 Mar 21 | 386,940 | 27,810 | 43,570 | 0 |
| 31 Dec 20 | 370,390 | 24,250 | 44,650 | 0 |
| 30 Sep 20 | 368,050 | 23,390 | 41,930 | 0 |
| 30 Jun 20 | 356,830 | 20,420 | 34,000 | 0 |
| 31 Mar 20 | 357,560 | 17,760 | 40,910 | 0 |
| 31 Dec 19 | 331,400 | 13,650 | 36,440 | 0 |
| 30 Sep 19 | 291,690 | 9,340 | 34,170 | 0 |
| 30 Jun 19 | 256,090 | 11,150 | 25,020 | 0 |
| 31 Mar 19 | 218,370 | 14,910 | 26,050 | 0 |
| 31 Dec 18 | 190,030 | 19,770 | 22,390 | 0 |
| 30 Sep 18 | 182,760 | 20,900 | 21,600 | 0 |
| 30 Jun 18 | 177,890 | 20,590 | 21,390 | 0 |
| 31 Mar 18 | 173,780 | 20,220 | 20,970 | 0 |
| 31 Dec 17 | 170,290 | 20,270 | 21,470 | 0 |
| 30 Sep 17 | 167,540 | 19,120 | 21,450 | 0 |
| 30 Jun 17 | 165,250 | 18,400 | 20,980 | 0 |
| 31 Mar 17 | 163,120 | 17,270 | 20,610 | 0 |
| 31 Dec 16 | 146,180 | 15,473 | 17,197 | 0 |
| 30 Sep 16 | 140,163 | 13,692 | 16,477 | 0 |
| 30 Jun 16 | 135,366 | 13,840 | 15,884 | 0 |
| 31 Mar 16 | 140,480 | 9,400 | 18,170 | 0 |
| 31 Dec 15 | 125,861 | 11,913 | 23,977 | 37 |
| 30 Sep 15 | 125,370 | 11,538 | 23,595 | 37 |
| 30 Jun 15 | 123,978 | 11,347 | 23,357 | 37 |
양질의 수익: 512070는 고품질 수익을 보유하고 있습니다.
이익 마진 증가: 512070의 현재 순 이익률 (3.7%)은 지난해 (1.6%)보다 높습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: 512070의 수익은 지난 5년 동안 연평균 30.1% 감소했습니다.
성장 가속화: 지난 1년간 512070 의 수익 증가율(152.6%)은 연간 평균(-30.1%)을 초과합니다.
수익 대 산업: 512070의 지난 1년 수익 증가율(152.6%)은 Chemicals 업계의 12.6%를 상회했습니다.
자기자본이익률
높은 ROE: 512070의 자본 수익률(5.4%)은 낮음으로 평가됩니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/06/10 13:19 |
| 종가 | 2026/06/10 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2026/03/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
UPL Limited는 40명의 분석가가 다루고 있습니다. 이 중 16명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Himanshu Binani | Anand Rathi Shares and Stock Brokers Limited |